Celsion Stock Price

-0.03 (-0.78%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Celsion Corp CLSN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.03 -0.78% 3.84 3.76 3.93 3.863 3.87 09:50:26
Bid Price Ask Price Spread Spread % News
3.82 3.84 0.02 0.52% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
525 166,595 $ 3.85 $ 641,091 4,366,374 0.6865 - 6.50
Last Trade Time Type Quantity Stock Price Currency
09:50:25 77 $ 3.8388 USD

Celsion Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 127.56M 33.22M 26.81M $ 500.00k $ - -0.76 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Celsion News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLSN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.814.503.093.812,348,7610.030.79%
1 Month2.886.502.704.153,901,2940.9633.33%
3 Months1.076.501.00013.452,372,6442.77258.88%
6 Months1.726.500.68653.231,233,7542.12123.26%
1 Year1.716.500.68653.07693,5182.13124.56%
3 Years1.926.500.68653.49740,2621.92100.0%
5 Years33.15238.080.68654.62708,535-29.31-88.42%

Celsion Description

Celsion Corp is active in the biotechnology market. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in Phase III clinical trial for the treatment of primary liver cancer and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.